HCPCS drug code · CMS crosswalk
Naropin J-Code / HCPCS Code
In short
Naropin is billed under HCPCS J2795 — Injection, ropivacaine hydrochloride, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 29 Naropin NDCs under this code.
Reference
- J2795
- Injection, ropivacaine hydrochloride, 1 mgBilling unit: 1 mg
- Labelers
- FreseniUS Kabi USA, LLC; Henry Schein Inc.
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.04
Per1 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Naropin units and claim line
Enter the dose given to get the J2795 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Naropin NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00404-9924-30 | J2795 | Henry Schein Inc. | 30 | 150 |
| 63323-0285-10 | J2795 | FreseniUS Kabi USA, LLC | 5 × 10 | 100 |
| 63323-0285-13 | J2795 | FreseniUS Kabi USA, LLC | 25 × 10 | 500 |
| 63323-0285-20 | J2795 | FreseniUS Kabi USA, LLC | 5 × 20 | 200 |
| 63323-0285-23 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 1000 |
| 63323-0285-28 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 1000 |
| 63323-0285-61 | J2795 | FreseniUS Kabi USA, LLC | 24 × 100 | 4800 |
| 63323-0285-63 | J2795 | FreseniUS Kabi USA, LLC | 24 × 200 | 9600 |
| 63323-0285-64 | J2795 | FreseniUS Kabi USA, LLC | 12 × 200 | 4800 |
| 63323-0285-65 | J2795 | FreseniUS Kabi USA, LLC | 12 × 100 | 2400 |
| 63323-0285-67 | J2795 | FreseniUS Kabi USA, LLC | 12 × 100 | 2400 |
| 63323-0285-68 | J2795 | FreseniUS Kabi USA, LLC | 12 × 100 | 2400 |
| 63323-0285-73 | J2795 | FreseniUS Kabi USA, LLC | 12 × 200 | 4800 |
| 63323-0286-00 | J2795 | FreseniUS Kabi USA, LLC | 12 × 100 | 6000 |
| 63323-0286-20 | J2795 | FreseniUS Kabi USA, LLC | 5 × 20 | 500 |
| 63323-0286-23 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 2500 |
| 63323-0286-27 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 2500 |
| 63323-0286-35 | J2795 | FreseniUS Kabi USA, LLC | 25 × 30 | 3750 |
| 63323-0286-38 | J2795 | FreseniUS Kabi USA, LLC | 25 × 30 | 3750 |
| 63323-0286-63 | J2795 | FreseniUS Kabi USA, LLC | 12 × 200 | 12000 |
| 63323-0286-95 | J2795 | FreseniUS Kabi USA, LLC | 25 × 30 | 3750 |
| 63323-0287-20 | J2795 | FreseniUS Kabi USA, LLC | 5 × 20 | 750 |
| 63323-0287-21 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 3750 |
| 63323-0288-10 | J2795 | FreseniUS Kabi USA, LLC | 5 × 10 | 500 |
| 63323-0288-11 | J2795 | FreseniUS Kabi USA, LLC | 25 × 10 | 2500 |
| 63323-0288-20 | J2795 | FreseniUS Kabi USA, LLC | 5 × 20 | 1000 |
| 63323-0288-21 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 5000 |
| 63323-0288-27 | J2795 | FreseniUS Kabi USA, LLC | 5 × 20 | 1000 |
| 63323-0288-29 | J2795 | FreseniUS Kabi USA, LLC | 25 × 20 | 5000 |
Naropin: common questions
- What is the J-code for Naropin?
- Naropin is billed under HCPCS J2795 — Injection, ropivacaine hydrochloride, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 29 Naropin NDCs under this code.
- How many J2795 billing units are in a package of Naropin?
- CMS lists 100 to 12,000 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is J2795 a CPT code?
- No. J2795 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.